Middle East & Africa Doxorubicin Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Drug Formulation (Lyophilized Powder and Doxorubicin Injection), Application (Breast Cancer, Kidney Cancer, Liver Cancer, Sarcoma, Ovarian Cancer, Lung Cancer, Leukemia, Multiple Myeloma, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
The MEA doxorubicin market is expected to grow from US$ 42.28 million in 2022 to US$ 52.76 million by 2028; it is estimated to grow at a CAGR of 3.8% from 2022 to 2028.
Both chemotherapy and targeted therapy significantly improve cancer patients' chances of survival and quality of life. These therapies may bring about the complete remission of a tumor. Owing to these benefits, the demand for chemotherapy has surged across the region. Advanced cancer treatments improve patient survival and increase long-term outpatient chemotherapy requirements. More exposure to chemotherapy results in a greater demand for doxorubicin drugs, thereby boosting the market growth across the region.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA doxorubicin market. The MEA doxorubicin market is expected to grow at a good CAGR during the forecast period.
MEA Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
MEA Doxorubicin Market Segmentation
The MEA doxorubicin market is segmented based on drug formulation, application, distribution channel, and country. Based on drug formulation, the MEA doxorubicin market is bifurcated into lyophilized powder and doxorubicin injection. The lyophilized powder segment dominated the market in 2022. Based on application, the MEA doxorubicin market is segmented into breast cancer, kidney cancer, liver cancer, sarcoma, ovarian cancer, lung cancer, leukemia, multiple myeloma, and others. The breast cancer segment dominated the market in 2022. Based on distribution channel, the MEA doxorubicin market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment dominated the market in 2022. Based on country, the MEA doxorubicin market has been categorized into the UAE, Saudi Arabia, South Africa, and rest of MEA. Our regional analysis states that Saudi Arabia dominated the market in 2022.
Accord Healthcare; Baxter International Inc.; Cipla Inc.; Dr. Reddy's Laboratories; Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.); Meiji Holdings Co., Ltd.; Novartis AG; Pfizer Inc.; Sun Pharmaceutical Industries Ltd; and Zydus Cadila are among the leading companies in the MEA doxorubicin market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Doxorubicin Market – By Drug Formulation
1.3.2 MEA Doxorubicin Market – By Application
1.3.3 MEA Doxorubicin Market – By Distribution Channel
1.3.4 MEA Doxorubicin Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Doxorubicin Market – Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Expert Opinion
5. MEA Doxorubicin Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Cancer
5.1.2 Increasing Preference for Chemotherapy
5.2 Market Restraints
5.2.1 Potential Side-effects Associated with Doxorubicin
5.3 Market Opportunities
5.3.1 Increasing Government Funding, Guidance, and Technical Assistance for Cancer Prevention
5.4 Future Trends
5.4.1 Increasing Approval of Generic Products
5.5 Impact Analysis
6. Doxorubicin Market– MEA Analysis
6.1 MEA Doxorubicin Market Revenue Forecast and Analysis
7. MEA Doxorubicin Market Analysis – By Drug Formulation
7.1 Overview
7.2 MEA Doxorubicin Market Share, By Drug Formulation 2022 & 2028 (%)
7.3 Lyophilized Powder
7.3.1 Overview
7.3.2 Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
7.4 Doxorubicin Injection
7.4.1 Overview
7.4.2 Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8. MEA Doxorubicin Market Analysis – By Application
8.1 Overview
8.2 MEA Doxorubicin Market Share, By Application 2022 & 2028 (%)
8.3 Breast Cancer
8.3.1 Overview
8.3.2 Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.4 Kidney Cancer
8.4.1 Overview
8.4.2 Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.5 Liver Cancer
8.5.1 Overview
8.5.2 Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.6 Sarcoma
8.6.1 Overview
8.6.2 Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.7 Ovarian Cancer
8.7.1 Overview
8.7.2 Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.8 Lung Cancer
8.8.1 Overview
8.8.2 Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.9 Leukemia
8.9.1 Overview
8.9.2 Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.10 Multiple Myeloma
8.10.1 Overview
8.10.2 Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.11 Others
8.11.1 Overview
8.11.2 Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
9. MEA Doxorubicin Market Analysis – By Disribution Channel
9.1 Overview
9.2 MEA Doxorubicin Market Share, By Disribution Channel 2022 & 2028 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
10. MEA Doxorubicin Market Analysis – By Country
10.1 Overview
10.1.1 MEA Doxorubicin Market Revenue and Forecast to 2028, by Country (%)
10.1.1.1 Saudi Arabia: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Saudi Arabia: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.2 Saudi Arabia: Doxorubicin Market, Revenue and Forecasts to 2028, By Drug Formulation (US$ Million)
10.1.1.1.3 Saudi Arabia: Doxorubicin Market, Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.1.1.4 Saudi Arabia: Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
10.1.1.2 South Africa: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 South Africa Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.2 South Africa: Doxorubicin Market, Revenue and Forecasts to 2028, By Drug Formulation (US$ Million)
10.1.1.3 South Africa: Doxorubicin Market, Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.1.3.1 South Africa: Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
10.1.1.4 UAE: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 UAE: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.2 UAE : Doxorubicin Market, Revenue and Forecasts to 2028, By Drug Formulation (US$ Million)
10.1.1.4.3 UAE : Doxorubicin Market, Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.1.4.4 UAE : Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
10.1.1.5 Rest of MEA: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Rest of MEA: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.2 Rest Of MEA: Doxorubicin Market, Revenue and Forecasts to 2028, By Drug Formulation (US$ Million)
10.1.1.5.3 Rest Of MEA: Doxorubicin Market, Revenue and Forecasts to 2028, By Application (US$ Million)
10.1.1.5.4 Rest Of MEA: Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Accord Healthcare
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Cipla Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Dr. Reddy's Laboratories
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Meiji Holdings Co., Ltd.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Novartis AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Pfizer Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Sun Pharmaceutical Industries Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Baxter International Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Zydus Cadila
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. MEA Doxorubicin Market, Revenue and Forecast, 2019–2028 (US$ Mn)
Table 2. Saudi Arabia Doxorubicin Market Revenue and Forecasts to 2028, By Drug Formulation (US$ Million).
Table 3. Saudi Arabia Doxorubicin Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 4. Saudi Arabia Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 5. South Africa Doxorubicin Market Revenue and Forecasts to 2028, By Drug Formulation (US$ Million).
Table 6. South Africa Doxorubicin Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 7. South Africa Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 8. Incidence, Mortality, and Prevalence by cancer site (2020)
Table 9. UAE Doxorubicin Market Revenue and Forecasts to 2028, By Drug Formulation (US$ Million).
Table 10. UAE Doxorubicin Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 11. UAE Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 12. Rest Of MEA Doxorubicin Market Revenue And Forecasts To 2028, By Drug Formulation (Us$ Million).
Table 13. Rest Of MEA Doxorubicin Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 14. Rest Of MEA Doxorubicin Market-Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 15. Organic Developments Done By Companies
Table 16. Inorganic Developments Done by Companies
Table 17. Glossary of Terms
LIST OF FIGURES
Figure 1. MEA Doxorubicin Market Segmentation
Figure 2. MEA Doxorubicin Market Segmentation, By Country
Figure 3. MEA Doxorubicin Market Overview
Figure 4. MEA Doxorubicin Market, By Drug Formulation
Figure 5. MEA Doxorubicin Market, By Country
Figure 6. MEA: PEST Analysis
Figure 7. MEA Doxorubicin Market Impact Analysis Of Driver And Restraints
Figure 8. MEA Doxorubicin Market– Revenue Forecast and Analysis
Figure 9. MEA Doxorubicin Devices Market Share, By Drug Formulation 2022 & 2028 (%)
Figure 10. MEA Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 11. MEA Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 12. MEA Doxorubicin Devices Market Share, By Application 2022 & 2028 (%)
Figure 13. MEA Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 14. MEA Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 15. MEA Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 16. MEA Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 17. MEA Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 18. MEA Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 19. MEA Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 20. MEA Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 21. MEA Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 22. MEA Doxorubicin Devices Market Share, By Disribution Channel 2022 & 2028 (%)
Figure 23. MEA Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 24. MEA Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 25. MEA Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 26. MEA Doxorubicin Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 27. MEA Doxorubicin Market Revenue and Forecast to 2028, by Country (%)
Figure 28. Saudi Arabia: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. South Africa: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. UAE: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. Rest of MEA: Doxorubicin Market Revenue and Forecast to 2028 (US$ Million)
- Accord Healthcare
- Baxter International Inc.
- Cipla Inc.
- Dr. Reddy's Laboratories
- Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)
- Meiji Holdings Co., Ltd.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Zydus Cadila
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA doxorubicin market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the MEA doxorubicin market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the doxorubicin market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution